Accelerating Early Access to Immunotherapies for Advanced Urothelial Carcinoma

Within one year, five immunotherapies have been approved for the treatment of patients with locally advanced or metastatic urothelial cancer. The availability of these immunotherapies brings challenges to all stakeholders in the field. Additional research is needed to identify biomarkers that are pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Autores principales: Ning, Yang‐Min, Maher, V. Ellen, Beaver, Julia A., Goldberg, Kirsten B., Blumenthal, Gideon M., Pazdur, Richard
Formato: Artigo
Lenguaje:Inglês
Publicado: AlphaMed Press 2017
Materias:
Editorial
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5813751/
https://ncbi.nlm.nih.gov/pubmed/29180460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0415
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares